Evidence map›Paper›PMID 11786497›Full record

ArticleBritish journal of pharmacology2002

Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.

A Alt, M J Clark, J H Woods, J R Traynor

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. GTPgammaS incorporation in the rat brain: a study on mu-opioid receptors and CXCR4.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2008
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A AltDepartment of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-0632, USA.
M J Clark
J H Woods
J R Traynor
University of Michigan–Ann Arbor · US

Funding

Selective radiolabeled agonists /antagonists for opiate receptor subtypesP50DA000254 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOSBERG, HENRY ISAAC · 1985 to 2002
$5.0M
Narcotic Drug and Opioid Peptide Basic Research projectP01DA000254 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WOODS, JAMES H · 2003 to 2006
$5.0M
COGNITIVE INTERVENTION FOR DRUG ABUSING ADOLESCENTSK21DA000254 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LATIMER, WILLIAM W · 1995 to 1999
–
NIDA NIH HHS DA00254NIDA NIH HHS K21 DA000254NIDA NIH HHS P01 DA000254NIDA NIH HHS P50 DA000254
6 · The paper itself

Abstract

1. There is evidence for interactions between mu and delta opioid systems both in vitro and in vivo. This work examines the hypothesis that interaction between these two receptors can occur intracellularly at the level of G protein in human neuroblastoma SH-SY5Y cells. 2. The [(35)S]GTP gamma S binding assay was used to measure G protein activation following agonist occupation of opioid receptors. The agonists DAMGO (EC(50), 45 nM) and SNC80 (EC(50), 32 nM) were found to be completely selective for stimulation of [(35)S]-GTP gamma S binding through mu and delta opioid receptors respectively. Maximal stimulation of [(35)S]-GTP gamma S binding produced by SNC80 was 57% of that seen with DAMGO. When combined with a maximally effective concentration of DAMGO, SNC80 caused no additional [(35)S]-GTP gamma S binding. This effect was also seen when measured at the level of adenylyl cyclase. 3. Receptor activation increased the dissociation of pre-bound [(35)S]-GTP gamma S. In addition, the delta agonist SNC80 promoted the dissociation of [(35)S]-GTP gamma S from G proteins initially labelled using the mu agonist DAMGO. Conversely, DAMGO promoted the dissociation of [(35)S]-GTP gamma S from G proteins initially labelled using SNC80. 4. Tolerance to DAMGO and SNC80 in membranes from cells exposed to agonist for 18 h was homologous and there was no evidence for alteration in G protein activity. 5. The findings support the hypothesis that mu- and delta-opioid receptors share a common G protein pool, possibly through a close organization of the two receptors and G protein at the plasma membrane.

Indexed as

Adenylyl CyclasesAnalgesics, OpioidBenzamidesCyclic AMPDose-Response Relationship, DrugDrug InteractionsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Enkephalin, D-Penicillamine (2,5)-GTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)HumansLigandsNeuroblastomaPiperazinesReceptors, Opioid, deltaReceptors, Opioid, mu4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamideAdenylyl CyclasesAnalgesics, OpioidBenzamidesCyclic AMPEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Enkephalin, D-Penicillamine (2,5)-GTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)LigandsPiperazinesReceptors, Opioid, deltaReceptors, Opioid, muSulfur Radioisotopes

Identifiers

PMID11786497
PMCPMC1573101
OpenAlexW1998440016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.